Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Snow Rothschild Acquisition Corp. Q3 2026 10-Q Filing

Snow Rothschild Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, covering its first months of operations following an initial public offering completed in June 2026.

Vinay Lochav | 13 November 2026

BM Acquisition Corp. Reports Q3 2026 Pre-IPO Financials

BM Acquisition Corp. filed a Form 10-Q with the SEC on November 13, 2026, covering the quarterly period ended September 30, 2026, disclosing its financial position as a blank check company incorporated in the Cayman Islands that had not yet commenced operations.

Nitish Kishor | 13 November 2026

Accelevation Holdings Files First Quarterly Report After June 2026 Formation

Accelevation Holdings Corp. filed its quarterly report for the period ended September 30, 2026, with the SEC on November 13, 2026, covering the company's first reporting period since its formation as a Delaware corporation on June 15, 2026.

Aakashdeep | 13 November 2026

Boston Omaha Q3 2026: Net Loss Narrows to $192K

Boston Omaha Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, reporting a net loss attributable to common stockholders of $192 thousand for the third quarter.

Aditi Sarkar | 13 November 2026

EGH Acquisition Corp. Reports Q3 2026 Results

EGH Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, covering operations as a Cayman Islands exempted company listed on Nasdaq.

Manish Choudhary | 13 November 2026

OptimizeRx Q3 2026: Net Income of $1.195M on $21.6M Revenue

OptimizeRx Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, reporting net income of $1.195 million for the third quarter and essentially breakeven results for the nine months year-to-date.

Aditi Sarkar | 13 November 2026

TherapeuticsMD Posts $741K Net Income for Nine Months Ended Sept 2026

TherapeuticsMD, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter and nine-month period ended September 30, 2026.

Aakashdeep | 13 November 2026

Everspin Technologies Q3 2026: Revenue Rises, Loss Widens

Everspin Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, reporting higher revenue alongside a wider operating loss compared to the same quarter a year earlier.

Anjali Anand | 13 November 2026

OptimizeRx Files 8-K for Q3 2026 Results and Updated Revenue Guidance

OptimizeRx Corporation filed a Form 8-K on November 13, 2026, reporting that it issued a press release on November 11, 2026, announcing financial results for the third quarter ended September 30, 2026, along with updated 2026 revenue guidance.

Nitish Kishor | 13 November 2026

ECA Marcellus Trust I Reports Q3 2026 Results

ECA Marcellus Trust I filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing royalty income, distributable income per unit, and trust corpus figures for the three and nine months ended on that date.

Aditi Sarkar | 13 November 2026
Support

Hi! How can we help you today?

Loading…